相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A. Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage
Michael N. Diringer et al.
STROKE (2008)
Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography
Guy Young et al.
BLOOD COAGULATION & FIBRINOLYSIS (2007)
Treatment of warfarin-associated intracerebral hemorrhage:: Literature review and expert opinion
Maria I. Aguilar et al.
MAYO CLINIC PROCEEDINGS (2007)
Normalization of platelet reactivity in clopidogrel-treated subjects
G. Vilahur et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation
Gerhard Dickneite
THROMBOSIS RESEARCH (2007)
Anticoagulants and their reversal
Sam Schulman et al.
TRANSFUSION MEDICINE REVIEWS (2007)
The role of recombinant activated factor VII in neurosurgery: hope or hype?
Gregory W. J. Hawryluk et al.
JOURNAL OF NEUROSURGERY (2006)
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage
Stephanie R. Earnshaw et al.
STROKE (2006)
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile
Jerrold H. Levy et al.
TRANSFUSION (2006)
Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy -: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates
Hagen B. Huttner et al.
STROKE (2006)
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
KA O'Connell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation
R. Altman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death
P Saloheimo et al.
STROKE (2006)
Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage
JN Goldstein et al.
STROKE (2006)
Rapid reversal of coagulopathy in patients on platelet aggregation inhibitors immediately prior to renal transplantation with recombinant factor VIIa?
H Loertzer et al.
TRANSPLANT INTERNATIONAL (2006)
Reversal of a potent investigational anticoagutant: Idraparinux with recombinant factor VIIa
A Dao et al.
AMERICAN JOURNAL OF MEDICINE (2005)
A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes
R MacLaren et al.
TRANSFUSION (2005)
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding:: A systematic review
M Levi et al.
CRITICAL CARE MEDICINE (2005)
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis
MI Chimowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Recombinant activated factor VII for acute intracerebral hemorrhage
SA Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation
M Yasaka et al.
THROMBOSIS RESEARCH (2005)
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral Hemorrhage
J Rosand et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
NR Bijsterveld et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Massive nasal bleeding and hemodynamic instability associated with clopidogrel
FE Nácul et al.
PHARMACY WORLD & SCIENCE (2004)
Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII
S Malherbe et al.
ANESTHESIOLOGY (2004)
Efficacy and safety of a prothrombin complex concentrate (Octaplex (R)) for rapid reversal of oral anticoagulation
A Lubetsky et al.
THROMBOSIS RESEARCH (2004)
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination
AMHP Van den Besselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation -: A prospective randomized controlled study
A Lubetsky et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Preparing for the new anticoagulants
BL Davidson
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects
B Sorensen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Desmopressin in mild hemophilia A: Indications, limitations, efficacy, and safety
S Lethagen
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2003)
The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments
PCA Kam et al.
ANAESTHESIA (2003)
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux
T Lisman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication
M Yasaka et al.
THROMBOSIS RESEARCH (2002)
The incidence of anaphylaxis following intravenous phytonadione (vitamin K1):: a 5-year retrospective review
DL Riegert-Johnson et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2002)
Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients
FE Preston et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin
HG Watson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
AA Weber et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Serial measurement of clotting factors in thawed plasma stored for 5 days
KA Downes et al.
TRANSFUSION (2001)
Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor
M Elg et al.
THROMBOSIS RESEARCH (2001)
Potential role of NovoSeven® in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage
JD Pickard et al.
BLOOD COAGULATION & FIBRINOLYSIS (2000)
Aspirin for the primary prevention of stroke and other major vascular events - Meta-analysis and hypotheses
RG Hart et al.
ARCHIVES OF NEUROLOGY (2000)